Parabolic Drugs reports standalone net loss of Rs 77.31 crore in the June 2016 quarter

Sales decline 49.65% to Rs 10.85 crore

Net Loss of Parabolic Drugs reported to Rs 77.31 crore in the quarter ended June 2016 as against net loss of Rs 76.84 crore during the previous quarter ended June 2015. Sales declined 49.65% to Rs 10.85 crore in the quarter ended June 2016 as against Rs 21.55 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales10.8521.55 -50 OPM %-295.30-158.05 -PBDT-63.93-59.76 -7 PBT-77.31-76.84 -1 NP-77.31-76.84 -1

Powered by Capital Market - Live News